Capsulomics, LLC

Capsulomics, LLC is a precision medicine startup from Johns Hopkins University focused on the prediction and detection of esophageal cancer. The company is commercializing the EsoCAN assay for esophageal squamous cell carcinoma (ESCC) diagnosis. Capsulomics is developing non-invasive molecular diagnostic solutions for early cancer detection.